Several specialized firms worldwide focus on the manufacture of complex medicinal APIs, notably Abacavir sulfate, Abarelix, and Abiraterone Acetate. These compounds present significant challenges in synthetic building due to their molecular complexity. The producers of these APIs often employ advanced processes and adhere to strict compliance proto